176 related articles for article (PubMed ID: 34102938)
1. Post-treatment heterogeneity of cardiometabolic risk in patients with acromegaly: The impact of GH and IGF-1.
Heydari M; Hashemi-Madani N; Emami Z; Khajavi A; Ghorbani M; Malek M; Ataei Kachuee M; Khamseh ME
Endocr Res; 2022 Feb; 47(1):1-7. PubMed ID: 34102938
[TBL] [Abstract][Full Text] [Related]
2. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
[TBL] [Abstract][Full Text] [Related]
3. Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly.
Zhang S; Li Y; Guo X; Gao L; Lian W; Yao Y; Feng M; Bao X; Wang R; Xing B
J Formos Med Assoc; 2018 Jan; 117(1):34-41. PubMed ID: 28341329
[TBL] [Abstract][Full Text] [Related]
4. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant.
Sesmilo G; Fairfield WP; Katznelson L; Pulaski K; Freda PU; Bonert V; Dimaraki E; Stavrou S; Vance ML; Hayden D; Klibanski A
J Clin Endocrinol Metab; 2002 Apr; 87(4):1692-9. PubMed ID: 11932303
[TBL] [Abstract][Full Text] [Related]
6. Changes in cardiovascular risk factors in patients with acromegaly after trans-sphenoidal adenomectomy.
Yen YS; Chen HS
Endocr J; 2020 Dec; 67(12):1169-1177. PubMed ID: 32713864
[TBL] [Abstract][Full Text] [Related]
7. Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly.
Serri O; Beauregard C; Hardy J
J Clin Endocrinol Metab; 2004 Feb; 89(2):658-61. PubMed ID: 14764777
[TBL] [Abstract][Full Text] [Related]
8. [Lowered ghrelin levels in acromegaly—normalization after treatment].
Kozakowski J; Rabijewski M; Zgliczyński W
Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
[TBL] [Abstract][Full Text] [Related]
9. Acromegaly with normal IGF-1 levels probably due to poorly controlled diabetes mellitus.
Arihara Z; Sakurai K; Yamada S; Murakami O; Takahashi K
Tohoku J Exp Med; 2008 Dec; 216(4):325-9. PubMed ID: 19060447
[TBL] [Abstract][Full Text] [Related]
10. Changing patterns of insulin-like growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly.
Espinosa-de-los-Monteros AL; Mercado M; Sosa E; Lizama O; Guinto G; Lopez-Felix B; Garcia O; Hernández I; Ovalle A; Mendoza V
J Neurosurg; 2002 Aug; 97(2):287-92. PubMed ID: 12186455
[TBL] [Abstract][Full Text] [Related]
11. The predictors of recovery from diabetes mellitus following neurosurgical treatment of acromegaly: A prospective study over a decade.
Dutta P; Hajela A; Gupta P; Rai A; Sachdeva N; Mukherjee KK; Pathak A; Dhandapani S
Neurol India; 2019; 67(3):757-762. PubMed ID: 31347550
[TBL] [Abstract][Full Text] [Related]
12. Divergence between growth hormone and insulin-like growth factor-i concentrations in the follow-up of acromegaly.
Alexopoulou O; Bex M; Abs R; T'Sjoen G; Velkeniers B; Maiter D
J Clin Endocrinol Metab; 2008 Apr; 93(4):1324-30. PubMed ID: 18230660
[TBL] [Abstract][Full Text] [Related]
13. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
Cardinal T; Rutkowski MJ; Micko A; Shiroishi M; Jason Liu CS; Wrobel B; Carmichael J; Zada G
Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
[TBL] [Abstract][Full Text] [Related]
14. Discordant growth hormone and IGF-1 levels post pituitary surgery in patients with acromegaly naïve to medical therapy and radiation: what to follow, GH or IGF-1 values?
Brzana JA; Yedinak CG; Delashaw JB; Gultelkin HS; Cook D; Fleseriu M
Pituitary; 2012 Dec; 15(4):562-70. PubMed ID: 22183781
[TBL] [Abstract][Full Text] [Related]
15. Acromegalic Cardiomyopathy: An Entity on its own? The Effects of GH and IGF-I Excess and Treatment on Cardiovascular Risk Factors.
Wolf P; Maione L; Kamenický P; Chanson P
Arch Med Res; 2023 Dec; 54(8):102921. PubMed ID: 38040526
[TBL] [Abstract][Full Text] [Related]
16. Cardiac and metabolic effects of chronic growth hormone and insulin-like growth factor I excess in young adults with pituitary gigantism.
Bondanelli M; Bonadonna S; Ambrosio MR; Doga M; Gola M; Onofri A; Zatelli MC; Giustina A; degli Uberti EC
Metabolism; 2005 Sep; 54(9):1174-80. PubMed ID: 16125529
[TBL] [Abstract][Full Text] [Related]
17. Cardiometabolic Risk in Acromegaly: A Review With a Focus on Pasireotide.
Puglisi S; Ferraù F; Ragonese M; Spagnolo F; Cannavò S
Front Endocrinol (Lausanne); 2020; 11():28. PubMed ID: 32117056
[TBL] [Abstract][Full Text] [Related]
18. Relationship between blood pressure and glucose tolerance in acromegaly.
Jaffrain-Rea ML; Moroni C; Baldelli R; Battista C; Maffei P; Terzolo M; Correra M; Ghiggi MR; Ferretti E; Angeli A; Sicolo N; Trischitta V; Liuzzi A; Cassone R; Tamburrano G
Clin Endocrinol (Oxf); 2001 Feb; 54(2):189-95. PubMed ID: 11207633
[TBL] [Abstract][Full Text] [Related]
19. Pulse wave velocity is decreased in acromegaly compared to non-acromegaly study participants with similar cardiovascular risk profile.
Filchenko I; Korostovtseva L; Bochkarev M; Boyarinova M; Alieva A; Rotar O; Sviryaev Y; Tsoi U; Grineva E
Growth Horm IGF Res; 2021; 57-58():101395. PubMed ID: 33962370
[TBL] [Abstract][Full Text] [Related]
20. Low serum IGF-I/GH ratio is associated with abnormal glucose tolerance in acromegaly.
Fukuoka H; Takahashi Y; Iida K; Kudo T; Nishizawa H; Imanaka M; Takeno R; Iguchi G; Takahashi K; Okimura Y; Kaji H; Chihara K
Horm Res; 2008; 69(3):165-71. PubMed ID: 18219220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
